/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

Daniel E. Fürst

University of California, Los Angeles(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

364

Papers

34.4K

Citations

81

h-index

236

i10-index

Daniel E. Fürst is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Systemic Sclerosis and Related Diseases & Systemic Lupus Erythematosus Research. The author has an h-index of 81, co-authored 310 publications.

ORCID: 0000-0002-4018-7629

Research Topics

Rheumatoid Arthritis Research and Therapies Systemic Sclerosis and Related Diseases Systemic Lupus Erythematosus Research Autoimmune and Inflammatory Disorders Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers by this author

works

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

2000 · New England Journal of Medicine · 3,006 citations

https://doi.org/10.1056/nejm200011303432202

Peter E. Lipsky Désirée van der Heijde E. William St. Clair Daniel E. Fürst

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

1999 · The Lancet · 2,342 citations

https://doi.org/10.1016/s0140-6736(99)05246-0

Ravinder N. Maini E. William St. Clair Ferdinand C. Breedveld Daniel E. Fürst

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

2005 · Arthritis & Rheumatism · 455 citations

https://doi.org/10.1002/art.20982

Josef S Smolen Chenglong Han M Bala Ravinder N. Maini

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

2014 · Annals of the Rheumatic Diseases · 232 citations

https://doi.org/10.1136/annrheumdis-2014-206106

Paul Emery Gerd R Burmester Vivian P. Bykerk Bernard Combe

Developing a Standardized Definition for Disease “Flare” in Rheumatoid Arthritis (OMERACT 9 Special Interest Group): Table 1.

2009 · The Journal of Rheumatology · 130 citations

https://doi.org/10.3899/jrheum.090369

Clifton O. Bingham Christoph Pohl Thasia Woodworth Sarah Hewlett

Outcome measurements in scleroderma: results from a delphi exercise.

2007 · PubMed · 72 citations

Hashim Gazi Janet Pope Philip J. Clements Thomas A. Medsger

Research topics

topics

Rheumatoid Arthritis Research and Therapies

Systemic Sclerosis and Related Diseases

Systemic Lupus Erythematosus Research

Autoimmune and Inflammatory Disorders Research

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Chat about Author

Papers

Chat

Click to start Chat